Eliciting and combining subjective judgments about uncertainty
- PMID: 2699470
- DOI: 10.1017/s026646230000845x
Eliciting and combining subjective judgments about uncertainty
Abstract
Frequently, health care decisions must be made before compelling and unequivocal evidence is available about the benefits, risks, and costs of a proposed new health technology. It is common for decision makers to seek the advice and opinions of experts to supplement the available evidence. This article reviews some of the methods used or recommended for eliciting the opinions of experts about uncertain events and for combining these opinions with those of others and with available empirical evidence.
Similar articles
-
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250. Health Technol Assess. 2010. PMID: 20501062 Review.
-
Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran.Health Policy Plan. 2017 May 1;32(4):504-515. doi: 10.1093/heapol/czw160. Health Policy Plan. 2017. PMID: 28025325
-
Decision analysis in forensic science.J Forensic Sci. 2005 Jul;50(4):894-905. J Forensic Sci. 2005. PMID: 16078494
-
Classic or Bayesian research design and analysis. Does it make a difference?Int J Technol Assess Health Care. 2002 Winter;18(1):120-6. Int J Technol Assess Health Care. 2002. PMID: 11987435
-
Bayesian methods in health technology assessment: a review.Health Technol Assess. 2000;4(38):1-130. Health Technol Assess. 2000. PMID: 11134920 Review.
Cited by
-
A comparison of two methods for expert elicitation in health technology assessments.BMC Med Res Methodol. 2016 Jul 26;16:85. doi: 10.1186/s12874-016-0186-3. BMC Med Res Methodol. 2016. PMID: 27456844 Free PMC article.
-
Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment.Pharmacoeconomics. 2013 Nov;31(11):991-1003. doi: 10.1007/s40273-013-0092-z. Pharmacoeconomics. 2013. PMID: 24105473